These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 32210298

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes.
    Evangelista EA, Kaspera R, Mokadam NA, Jones JP, Totah RA.
    Drug Metab Dispos; 2013 Dec; 41(12):2087-94. PubMed ID: 24021950
    [Abstract] [Full Text] [Related]

  • 3. Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II.
    He Z, Zhang X, Chen C, Wen Z, Hoopes SL, Zeldin DC, Wang DW.
    Cardiovasc Res; 2015 Mar 01; 105(3):304-17. PubMed ID: 25618409
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Endothelium-specific CYP2J2 overexpression improves cardiac dysfunction by promoting angiogenesis via Jagged1/Notch1 signaling.
    Zhao Q, Huang J, Wang D, Chen L, Sun D, Zhao C.
    J Mol Cell Cardiol; 2018 Oct 01; 123():118-127. PubMed ID: 30219518
    [Abstract] [Full Text] [Related]

  • 7. Enhancement of cardiac L-type Ca2+ currents in transgenic mice with cardiac-specific overexpression of CYP2J2.
    Xiao YF, Ke Q, Seubert JM, Bradbury JA, Graves J, Degraff LM, Falck JR, Krausz K, Gelboin HV, Morgan JP, Zeldin DC.
    Mol Pharmacol; 2004 Dec 01; 66(6):1607-16. PubMed ID: 15361551
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPKα2 and enhancing nuclear translocation of Akt1.
    Wang B, Zeng H, Wen Z, Chen C, Wang DW.
    Aging Cell; 2016 Oct 01; 15(5):940-52. PubMed ID: 27416746
    [Abstract] [Full Text] [Related]

  • 12. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
    Xu M, Ju W, Hao H, Wang G, Li P.
    Drug Metab Rev; 2013 Aug 01; 45(3):311-52. PubMed ID: 23865864
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cardiomyocyte-specific CYP2J2 and its therapeutic implications.
    Valencia R, Bassiouni W, Darwesh AM, Bapuji R, Seubert JM.
    Expert Opin Drug Metab Toxicol; 2022 Aug 01; 18(7-8):423-439. PubMed ID: 35997132
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and p42/p44 MAPK pathway.
    Seubert J, Yang B, Bradbury JA, Graves J, Degraff LM, Gabel S, Gooch R, Foley J, Newman J, Mao L, Rockman HA, Hammock BD, Murphy E, Zeldin DC.
    Circ Res; 2004 Sep 03; 95(5):506-14. PubMed ID: 15256482
    [Abstract] [Full Text] [Related]

  • 17. CYP2J2-derived EETs attenuated ethanol-induced myocardial dysfunction through inducing autophagy and reducing apoptosis.
    Zhou C, Huang J, Li Q, Zhan C, Xu X, Zhang X, Ai D, Zhu Y, Wen Z, Wang DW.
    Free Radic Biol Med; 2018 Mar 03; 117():168-179. PubMed ID: 29427791
    [Abstract] [Full Text] [Related]

  • 18. CYP epoxygenase 2J2 prevents cardiac fibrosis by suppression of transmission of pro-inflammation from cardiomyocytes to macrophages.
    Yang L, Ni L, Duan Q, Wang X, Chen C, Chen S, Chaugai S, Zeldin DC, Tang JR, Wang DW.
    Prostaglandins Other Lipid Mediat; 2015 Mar 03; 116-117():64-75. PubMed ID: 25686540
    [Abstract] [Full Text] [Related]

  • 19. Epoxyeicosatrienoic acids limit damage to mitochondrial function following stress in cardiac cells.
    Katragadda D, Batchu SN, Cho WJ, Chaudhary KR, Falck JR, Seubert JM.
    J Mol Cell Cardiol; 2009 Jun 03; 46(6):867-75. PubMed ID: 19285984
    [Abstract] [Full Text] [Related]

  • 20. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.
    Li R, Xu X, Chen C, Wang Y, Gruzdev A, Zeldin DC, Wang DW.
    Am J Physiol Endocrinol Metab; 2015 Feb 15; 308(4):E270-82. PubMed ID: 25389363
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.